COVID-19 Vaccine Assessments In Omaha Present 95% Effectiveness

OMAHA, Neb. (WOWT) – As COVID-19 hospital stays on the subway hit a new record high, there is promising news in the field of vaccines.

At Meridian Clinical Research, in northwest Omaha, more than 1,700 Nebraskans have volunteered to participate in the Moderna and Pfizer clinical trials for a COVID-19 vaccine.

Pfizer brought encouragement last week, while on Monday, independent observers rated the vaccine nearly 95 percent effective, according to Moderna.

“We’re both relatively young and healthy and wanted to do our part to help everyone,” said Omaha’s Nick Delman.

In August, Delman and his wife signed up for the Moderna clinical trial, which tested a vaccine against COVID-19.

“The process was easy. They did a physical exam and then we were given half a dose and then they monitored us for seven days to see if we had any side effects from the shot, “he said.

When asked if he didn’t know whether he received the vaccine or a placebo, Delman said, “Right. With the double blind, it’s a 50:50 chance. It’s exciting to know that maybe I got the healing. “

Delman is among the 30,000 people participating in the process.

On Sunday, an independent committee examined 95 volunteers who became infected after a second dose.

All but five who got sick were given the placebo – not the Moderna vaccine.

This corresponds to an effectiveness rate of 95 percent.

“Everyone has to make adjustments,” said Dr. Rudolf Kotula, Infectious Disease Specialist at Methodist Health Systems.

Kotula knows this is a critical time on the subway – everyone needs to rethink holiday gatherings as COVID-19 hospital stays escalate.

Perhaps this vaccine news is encouraging enough to get us through the pandemic fatigue.

“I think that’s an incredible amount of effectiveness. We have 2 excellent candidates – Pfizer and Moderna. Both look like very effective vaccines, “said Kotual.

Experts keep beating the drum of wearing masks, which is an easy way to help our neighbors.

The vaccine volunteers see their efforts the same way.

“It’s really hard to see people get hurt, in pain, and even die without a family. Anything to help these people and the healthcare workers – to support these people when their families can’t be there, “Delman said.

If the effectiveness numbers stay that way – experts say 20 million doses of the vaccine could be available to the most vulnerable by December.

And then millions by early next year.

One big difference between Moderna’s vaccine and Pfizer is that Modernas doesn’t need to be stored at incredibly low temperatures.

Copyright 2020 WOWT. All rights reserved.

Comments are closed.